Asian Phytoceuticals PCL (BKK:APCO)
Thailand
· Delayed Price · Currency is THB 3.140
+0.180 (6.08%)
Mar 7, 2025, 4:12 PM ICT
Asian Phytoceuticals PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 210.83 | 292.76 | 250.38 | 223.35 | 247.73 | Upgrade
|
| Revenue Growth (YoY) | -27.99% | 16.93% | 12.10% | -9.84% | 0.03% | Upgrade
|
| Cost of Revenue | 40.96 | 57.25 | 47.94 | 46.26 | 52.87 | Upgrade
|
| Gross Profit | 169.87 | 235.52 | 202.44 | 177.09 | 194.85 | Upgrade
|
| Selling, General & Admin | 120.1 | 119.72 | 116.49 | 106.29 | 124.73 | Upgrade
|
| Other Operating Expenses | -3.34 | -1.09 | -2.08 | -3.03 | -5.41 | Upgrade
|
| Operating Expenses | 116.76 | 118.63 | 114.41 | 103.27 | 119.32 | Upgrade
|
| Operating Income | 53.11 | 116.89 | 88.03 | 73.82 | 75.53 | Upgrade
|
| Interest Expense | -1.59 | -0.66 | -0.57 | -0.86 | -0.48 | Upgrade
|
| Interest & Investment Income | 13.05 | 15.22 | 12.41 | 10.31 | 4.41 | Upgrade
|
| Earnings From Equity Investments | 1.67 | 1.26 | 0.61 | -0.28 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 66.24 | 132.72 | 100.48 | 82.98 | 79.45 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.73 | 0.47 | -0.01 | 2.51 | 7.61 | Upgrade
|
| Pretax Income | 67.98 | 133.18 | 100.47 | 85.49 | 87.07 | Upgrade
|
| Income Tax Expense | 12.21 | 24.45 | 19.28 | 16.79 | 17.09 | Upgrade
|
| Earnings From Continuing Operations | 55.77 | 108.74 | 81.2 | 68.7 | 69.98 | Upgrade
|
| Minority Interest in Earnings | -1.06 | -1.24 | -0.28 | - | - | Upgrade
|
| Net Income | 54.71 | 107.49 | 80.92 | 68.7 | 69.98 | Upgrade
|
| Net Income to Common | 54.71 | 107.49 | 80.92 | 68.7 | 69.98 | Upgrade
|
| Net Income Growth | -49.10% | 32.84% | 17.78% | -1.82% | 20.85% | Upgrade
|
| Shares Outstanding (Basic) | 601 | 601 | 600 | 600 | 600 | Upgrade
|
| Shares Outstanding (Diluted) | 601 | 601 | 600 | 600 | 600 | Upgrade
|
| Shares Change (YoY) | 0.12% | 0.12% | -0.03% | -0.02% | 0.01% | Upgrade
|
| EPS (Basic) | 0.09 | 0.18 | 0.13 | 0.11 | 0.12 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.18 | 0.13 | 0.11 | 0.12 | Upgrade
|
| EPS Growth | -49.16% | 32.69% | 17.82% | -1.80% | 20.83% | Upgrade
|
| Free Cash Flow | 35.36 | 120.72 | 99.86 | 83.22 | 82.57 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.20 | 0.17 | 0.14 | 0.14 | Upgrade
|
| Dividend Per Share | 0.092 | 0.180 | 0.155 | 0.123 | 0.120 | Upgrade
|
| Dividend Growth | -48.89% | 16.13% | 25.61% | 2.83% | 26.32% | Upgrade
|
| Gross Margin | 80.57% | 80.45% | 80.85% | 79.29% | 78.66% | Upgrade
|
| Operating Margin | 25.19% | 39.93% | 35.16% | 33.05% | 30.49% | Upgrade
|
| Profit Margin | 25.95% | 36.72% | 32.32% | 30.76% | 28.25% | Upgrade
|
| Free Cash Flow Margin | 16.77% | 41.24% | 39.88% | 37.26% | 33.33% | Upgrade
|
| EBITDA | 59.29 | 123.69 | 94.84 | 81.48 | 87.51 | Upgrade
|
| EBITDA Margin | 28.12% | 42.25% | 37.88% | 36.48% | 35.32% | Upgrade
|
| D&A For EBITDA | 6.18 | 6.8 | 6.81 | 7.66 | 11.97 | Upgrade
|
| EBIT | 53.11 | 116.89 | 88.03 | 73.82 | 75.53 | Upgrade
|
| EBIT Margin | 25.19% | 39.93% | 35.16% | 33.05% | 30.49% | Upgrade
|
| Effective Tax Rate | 17.96% | 18.36% | 19.19% | 19.64% | 19.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.